1. CALR loss-of-heterozygosity as a potential driver for extramedullary AML.
- Author
-
Weller, Marie-Christine, Haralambieva, Eugenia, Bühler, Marco Matteo, Benz, Rudolf, Theocharides, Alexandre Pierre André, and Balabanov, Stefan
- Subjects
- *
ACUTE myeloid leukemia , *SOMATIC mutation , *EXTRAMEDULLARY diseases , *MYELOID sarcoma , *MYELOFIBROSIS , *MYELOPROLIFERATIVE neoplasms , *GENETIC mutation , *GENETIC carriers , *CALCIUM-binding proteins - Abstract
So far, only very few AML patients, harboring a I CALR i mutation, have been described. Dear Editor, Core binding factor acute myeloid leukemia (AML) patients with the recurrent genetic anomaly I RUNX1-RUNX1T1 i represent an AML subgroup with favorable risk [[1]]. [[4], [6]] We report for the first time to our knowledge a case of an AML patient with I RUNX1-RUNX1T1 i translocation and concomitant I CALR i mutation. [Extracted from the article]
- Published
- 2022
- Full Text
- View/download PDF